Table 3.
Adverse events of 14-day hybrid therapy
Adverse Events | Hybrid therapy (n = 117) |
---|---|
Abdominal pain | 4 (1/2/1) |
Constipation | 0 (0/0/0) |
Diarrhea | 8 (6/1/1) |
Dizziness | 6 (4/1/1) |
Taste perversion | 8 (7/1/0) |
Headache | 5 (4/1/0) |
Anorexia | 1 (1/0/0) |
Nausea | 3 (0/1/2) |
Vomiting | 2 (0/1/1) |
Skin rash | 1 (0/0/1) |
Fatigue | 2 (2/0/0) |
Others | 4 (2/1/1) |
Numbers of patients who suffered from mild, moderate and severe adverse events.